Katalin Susztak, MD, PHD
Accepting new patients
Sees patients age 18 and up
Penn Medicine Provider

About me

  • Professor of Medicine (Renal-Electrolyte and Hypertension)
  • Professor of Medicine in Genetics
  • Professor of Medicine in Pediatrics

Insurance accepted

My Locations

Qualifications and experience

Treatments and Conditions

My research

Yuan M, Jin K, Yan H, Schroeder A, Luo C, Yao S, Dumoulin B, Levinsohn J, Luo T, Clemenceau J, Jang I, Kim M, Liu Y, Deng M, Furth EE, Wilson P, Nayak A, Lubo I, Soto LMS, Wang L, Park JH, Susztak K, Hwang TH, Li M. Designing smart spatial omics experiments with S2Omics , bioRxiv: 2025


Martinez Leon V, Hilburg R, Susztak K. Mechanisms of diabetic kidney disease and established and emerging treatments , Nat Rev Endocrinol: 2025


Anandh U, Anders HJ, Bacchetta J, Johnson DW, Luyckx V, Remuzzi G, Rodriguez-Iturbe B, Susztak K, Tuttle K, Yanagita M. Two decades of nephrology research: progress and future challenges , Nat Rev Nephrol: 2025


Li C, Marschner JA, Kusunoki Y, Zhang N, Li X, Deng H, Zhao Z, Watanabe-Kusunoki K, Zhu Z, Xu Y, Steiger S, Lech M, Susztak K, Schulz C, Anders HJ. Macrophage Zc3h12c Limits Tissue Inflammation and Injury via Alternative Splicing of Pre-mRNA , Adv Sci (Weinh): 2025


Md Dom ZI, Moon S, Satake E, Hirohama D, Palmer ND, Lampert H, Ficociello LH, Abedini A, Fernandez K, Liang X, Pickett S, Levinsohn J, O'Neil K, Dillon ST, Mauer M, Galecki AT, Freedman BI, Susztak K, Doria A, Krolewski AS, Niewczas MA. Urinary Complement proteome strongly linked to diabetic kidney disease progression , Nat Commun, 16: 2025,7291


Hirohama D, Fadista J, Ha E, Liu H, Abedini A, Levinsohn J, Vassalotti A, Zeng L, Li C, Mohandes S, Vitale S, Shungin D, Nguyen T, Niewczas MA, Olsson N, McAllister FE, Karihaloo A, Susztak K. The proteogenomic landscape of the human kidney and implications for cardio-kidney-metabolic health , Nat Med: 2025


Ojo AO, Adu D, Bramham K, Freedman BI, Gbadegesin RA, Ilori TO, Jefferson N, Olabisi OA, Susztak K, Young BA, Cheung M, King JM, Grams ME, Jadoul M, Ulasi II; Conference Participants. APOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference , Kidney Int: 2025


Cole JB, Dahlström EH, Fermin D, Gupta Y, Hill C, Smyth LJ, Liu H, Kreienkamp RJ, Pezzolesi MG, Cao JJ, Valo E, Chen WM, Onengut-Gumuscu S, Rich SS, Brennan EP, Andrews D, Kennedy C, Gu HF, Stechemesser L, Weitgasser R, Sokolovska J, Radzeviciene L, Verkauskiene R, Panduru NM, Rossing P, Ahluwalia TS, Zerbini G, Marre M, Hadjadj S, Costacou T, Miller RG, Klein BE, Lee KE, Snell-Bergeon JK, Caramori ML, Mauer M, Brismar K, Bjornstad P, McKnight AJ, McKay G, Nair V, Salem RM, Groop PH, Godson C, Susztak K, Kretzler M, Maxwell AP, Krolewski A, Paterson A, Sandholm-Lafferre N, Florez JC, Hirschhorn JN. Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci , J Am Soc Nephrol: 2025


Kolligundla LP, Sullivan KM, Mukhi D, Andrade-Silva M, Liu H, Guan Y, Gu X, Wu J, Doke T, Hirohama D, Guarnieri P, Hill J, Pullen SS, Kuo J, Inamoto M, Susztak K. Glutathione-specific gamma-glutamylcyclotransferase 1 (CHAC1) increases kidney disease risk by modulating ferroptosis , Sci Transl Med, 17: 2025,eadn3079


Mukhi D, Kolligundla LP, Doke T, Silva MA, Liu H, Palmer M, Susztak K. The actin and microtubule network regulator WHAMM is identified as a key kidney disease risk gene , Cell Rep, 44: 2025,115462


View all publications